We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WHO Cites India’s Svizera Labs for GMP, Data Integrity Issues
WHO Cites India’s Svizera Labs for GMP, Data Integrity Issues
Yet another Indian drugmaker has been dinged for serious data integrity and GMP issues — this time during a June 4 to 7 inspection by the World Health Organization.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor